Evidence map›Paper›PMID 21177780›Full record

ArticleAmerican journal of physiology. Renal physiology2011

ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate.

Valentin David, Aline Martin, Anne-Marie Hedge, Marc K Drezner, Peter S N Rowe

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The Intricacies of Renal Phosphate Reabsorption-An Overview.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. PHEXGenes · 2022
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Do ASARM peptides play a role in nephrogenic systemic fibrosis?American journal of physiology. Renal physiology · 2015
    Article
  14. Article
  15. Review
  16. Article
  17. Mathematical model for bone mineralization.Frontiers in cell and developmental biology · 2015
    Article
  18. Article
  19. Osteocytes: master orchestrators of bone.Calcified tissue international · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Valentin DavidUniversity of Tennessee Health Science Center, Memphis, Tennessee, USA.
Aline Martin
Anne-Marie Hedge
Marc K Drezner
Peter S N Rowe
University of Tennessee Health Science Center · USGeriatric Research Education and Clinical Center · USUniversity Medical Center · USUniversity of Kansas Medical Center · US

Funding

ZOSUQUIDAR TRIHYDROCHLORIDE IN NEWLY DIAGNOSED AMLM01RR003186 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI TRAYNOR, ANNE M · 1986 to 2007
$19.3M
PATHOGENESIS OF VITAMIN D REFRACTORY DISEASESR01AR027032 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 1986 to 2015
$3.5M
Mineralization of the matrix in disease and healthR01AR051598 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI ROWE, PETER S · 2004 to 2013
$2.8M
Mentored Clinical Research Scholar Program AwardK12RR017614 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI GRAZIANO, FRANK M · 2003 to 2007
$1.9M
NCRR NIH HHS 1K12-RR-017614NCRR NIH HHS M01 RR003186NCRR NIH HHS M01-RR-03186-21NIAMS NIH HHS R01 AR027032NIAMS NIH HHS R01 AR051598NIAMS NIH HHS R01-AR-27032-26NIAMS NIH HHS R0-1-AR51598-01
6 · The paper itself

Abstract

Increased acidic serine aspartate-rich MEPE-associated motif (ASARM) peptides cause mineralization defects in X-linked hypophosphatemic rickets mice (HYP) and "directly" inhibit renal phosphate uptake in vitro. However, ASARM peptides also bind to phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) and are a physiological substrate for this bone-expressed, phosphate-regulating enzyme. We therefore tested the hypothesis that circulating ASARM peptides also "indirectly" contribute to a bone-renal PHEX-dependent hypophosphatemia in normal mice. Male mice (n = 5; 12 wk) were fed for 8 wk with a normal phosphorus and vitamin D(3) diet (1% P(i) diet) or a reduced phosphorus and vitamin D(3) diet (0.1% P(i) diet). For the final 4 wk, transplantation of mini-osmotic pumps supplied a continuous infusion of either ASARM peptide (5 mg·day(-1)·kg(-1)) or vehicle. HYP, autosomal recessive hypophosphatemic rickets (ARHR), and normal mice (no pumps or ASARM infusion; 0.4% P(i) diet) were used in a separate experiment designed to measure and compare circulating ASARM peptides in disease and health. ASARM treatment decreased serum phosphate concentration and renal phosphate cotransporter (NPT2A) mRNA with the 1% P(i) diet. This was accompanied by a twofold increase in serum ASARM and 1,25-dihydroxy vitamin D(3) [1,25 (OH)(2)D(3)] levels without changes in parathyroid hormone. For both diets, ASARM-treated mice showed significant increases in serum fibroblast growth factor 23 (FGF23; +50%) and reduced serum osteocalcin (-30%) and osteopontin (-25%). Circulating ASARM peptides showed a significant inverse correlation with serum P(i) and a significant positive correlation with fractional excretion of phosphate. We conclude that constitutive overexpression of ASARM peptides plays a "component" PHEX-independent part in the HYP and ARHR hypophosphatemia. In contrast, with wild-type mice, ASARM peptides likely play a bone PHEX-dependent role in renal phosphate regulation and FGF23 expression. They may also coordinate FGF23 expression by competitively modulating PHEX/DMP1 interactions and thus bone-renal mineral regulation.

Indexed as

Aspartic AcidSerineAmino Acid SequenceAnimalsExtracellular Matrix ProteinsFibroblast Growth Factor-23Fibroblast Growth FactorsGlycoproteinsHypophosphatemiaKidneyMaleMiceMice, Inbred C57BLModels, AnimalMolecular Sequence DataPeptidesAspartic AcidDmp1 protein, mouseExtracellular Matrix ProteinsFgf23 protein, mouseFibroblast Growth Factor-23Fibroblast Growth FactorsGlycoproteinsMepe protein, mousePeptidesPHEX Phosphate Regulating Neutral EndopeptidasePhex protein, mousePhosphatesPhosphoproteinsSerineSlc34a1 protein, mouseSodium-Phosphate Cotransporter Proteins, Type IIa

Identifiers

PMID21177780
PMCPMC3064126
OpenAlexW2022516405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.